高级搜索

男性乳腺癌的临床病理特征与预后的相关性分析—40例临床资料总结

李杰华, 严峻

李杰华, 严峻. 男性乳腺癌的临床病理特征与预后的相关性分析—40例临床资料总结[J]. 肿瘤防治研究, 2012, 39(12): 1460-1463. DOI: 10.3971/j.issn.1000-8578.2012.12.013
引用本文: 李杰华, 严峻. 男性乳腺癌的临床病理特征与预后的相关性分析—40例临床资料总结[J]. 肿瘤防治研究, 2012, 39(12): 1460-1463. DOI: 10.3971/j.issn.1000-8578.2012.12.013
Li Jiehua, Yan Jun. Analysis of Clinical Features and Prognostic Factors of Male Breast Cancer:A Review of 40 Cases[J]. Cancer Research on Prevention and Treatment, 2012, 39(12): 1460-1463. DOI: 10.3971/j.issn.1000-8578.2012.12.013
Citation: Li Jiehua, Yan Jun. Analysis of Clinical Features and Prognostic Factors of Male Breast Cancer:A Review of 40 Cases[J]. Cancer Research on Prevention and Treatment, 2012, 39(12): 1460-1463. DOI: 10.3971/j.issn.1000-8578.2012.12.013

男性乳腺癌的临床病理特征与预后的相关性分析—40例临床资料总结

详细信息
    作者简介:

    李杰华(1978-),男,博士在读,主治医师,主要从事乳腺外科的研究

  • 中图分类号: R737.9

Analysis of Clinical Features and Prognostic Factors of Male Breast Cancer:A Review of 40 Cases

  • 摘要: 目的 探讨影响男性乳腺癌患者预后的因素。方法回顾性总结1990年1月—2011年5月在广西医科大学第一附属医院收治的40例男性乳腺癌患者的临床资料。采用Kaplan-Meier法、Cox比例风险回归模型和Log rank 检验分析影响男性乳腺癌患者预后的因素。结果本组全部40例男性乳腺癌患者均随访,5年总生存率为67.5%。单因素分析显示,患者的预后与肿瘤大小、腋窝淋巴结转移、ER和PR、TNM 分期、手术方式、有无内分泌治疗等因素有关(P<0.05)。多因素分析显示,TNM 分期、有无手术和有无内分泌治疗是影响预后的重要因素。结论早期诊断和以手术为主、辅以内分泌治疗的综合治疗能够提高男性乳腺癌患者生存率。

     

    Abstract: Objective To investigate the prognostic factors in patients with male breast cancer(MBC). Methods A total of 40 patients with MBC treated in the First Affiliated Hospital of Guangxi Medical University between January,1990 and May,2011 were analyzed retrospectively.Kaplan-Meier,Log rank test and Cox regression model were used to analyze the prognostic variables. Results The follow-up rate was 100%.The total 5-year overall survival was 67.5%.Univariate analysis indicated that the tumor size,axillary lymph node status,ER and PR status,TNM stage,operation model and endocrine therapy were significant predictors of survival.Multivariate analysis showed that TNM stage,operation model and endocrine therapy were independent prognostic factors. Conclusion Early diagnosis and comprehensive treatment consisting of operation and endocrine therapy can significantly improve the survival of MBC.

     

  • [1] Anderson WF,Athuis MD,Brinton LA,et al.Is male breast cancer similar or different than female breast cancer?[J].Breast Cancer Res Treat,2004,83(1):77- 86.
    [2] Giordano SH,Cohen DS,Buzdar AU,et al.Breast carcinoma in men:a population-based study[J].Cancer,2004,101 (1):51-7.
    [3] Zhou ZX,Shao YF,Hou HR,et al.Diagnosis and treatment of male breast carcinoma[J].Zhonghua Zhong Liu Za Zhi,1998,20(3):235-6.[周志祥,邵永孚,侯惠荣,等.男性乳腺癌的诊断与治疗[J].中华肿瘤杂志,1998,20(3):235-6.]
    [4] Johnson KC,Pan S,Mao Y,et al.Risk factors for male breast cancer in canda,1994-1998[J].Eur J Cancer Prev,2002,11(3):253-63.
    [5] Agrawal A,Ayantunde AA,Rampaul R,et al.Male breast cancer:a review of clinical management[J].Breast Cancer Res Treat,2007,103(1):11-21.
    [6] Pant I,Joshi SC.Invasive papillary carcinoma of the male breast:report of a rare case and rev iew of the literature [J].J Cancer Res Ther,2009,5(3):216-8.
    [7] Gentilini O,Chagas E,Zurrida S,et al.Sentinel lymph node biopsy in male patients with early breast cancer [J ].Oncologist,2007,12(5):512-5.
    [8] Zhang HM,Zhang BN.Analysis of diagnosis and treatment for 30 cases with male brest cancer[J].Lin Chuang Zhong Liu Xue Za Zhi,2008,13(12):1081-4.[张慧明,张保宁.男性乳腺癌30例诊治体会[J].临床肿瘤学杂志,2008,13 (12):1081-4.]
    [9] Giordano SH.A review of the diagnosis and management of male breast cancer[J].Oncologist,2005,10(7):471-9.
    [10] Murphy CE,Carder PJ,Lansdown MR,et al.Steroid hormone receptor ex pression in male breast cancer [J].Eur J Surg Oncol,2006,32(1):44-7.
    [11] Zhou FF,Xia LP,Guo GF,et al.Changes in therapeutic strategies in Chinese male patients with breast cancer:40 years of experience in a single institute [J].Breast,2010,19(6):450-5.
    [12] Cutuli B,Le Nir CC,Serin D,et al.Male breast cancer.Evolution of treatment and prognostic factors.Analysis of 489 cases[J].Crit Rev Oncol Hematol,2010,73(3):246-54.
    [13] El-Tamer MB,Komenaka IK,Troxel A,et al.Men with breast cancer have better disease-specific survival than women [J].Arch Surg,2004,139(10):1079-82.
    [14] Wang J,Kollias J,Marsh C,et al.Are males with early breast cancer treated differently from females with early breast cancer in Australia and New Zealand?[J].Breast,2009,18(6):378-81.
    [15] Santeufemia DA,Capobianco G,Dessole S,et al.Tamoxifen induced severe hypertriglyceridemia in a male patient with breast carcinoma [J].Breast J,2009,15(6):675-6.
    [16] Giordano SH,Perkins GH,Broglio K,et al.Adjuvant systemic therapy for male breast carcinoma[J].Cancer,2005,104(11):2359-64.
    [17] Gennari R,Curigliano G,Jereczek-Fossa BA,et al.Malebreast cancer:A special therapeutic problem.Anythingnew [J].Int J Oncol,2004,24(3):663-70.
计量
  • 文章访问数: 
  • HTML全文浏览量:  0
  • PDF下载量: 
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-02-02
  • 修回日期:  2012-06-04
  • 刊出日期:  2012-12-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭